Table 1.
pCR | Non-pCR | GR | Non-GR | |
---|---|---|---|---|
Pre-treatment (N=45) | N=10 | N=35 | N=31 | N=14 |
Male:Female | 5:5 | 26:9 | 21:10 | 10:4 |
Mean age (SD) | 56.3 (11.1) | 59.7 (8.0) | 58.0 (9.0) | 61.1 (8.1) |
Mean tumor volume (SD, cm3) | 14.2 (6.0)* | 21.5 (15.8)* | 15.3 (8.7)‡ | 28.0 (18.9)‡ |
Mean ADC (SD, mm2/s) | 0.93 (0.09) | 0.95 (0.14) | 0.94 (0.14) | 0.94 (0.11) |
Mid-RT follow-up (N=41) | N=9 | N=32 | N=27 | N=14 |
Male:Female | 5:4 | 23:9 | 18:9 | 10:4 |
Mean age (SD) | 56.4 (11.8) | 60.3 (7.9) | 58.3 (9.5) | 61.9 (7.5) |
Mean tumor volume (SD, cm3) | 6.6 (4.5)** | 11.7 (12.1)** | 6.8 (6.1)‡‡ | 17.7 (14.5)‡‡ |
Mean ADC (SD, mm2/s) | 1.33 (0.16) | 1.37 (0.18) | 1.36 (0.19) | 1.33 (0.15) |
The volume is significantly smaller in pCR than in non-pCR (* p=0.009, ** p=0.047)
The volume is significantly smaller in GR than in non-GR (‡ p=0.01, ‡‡ p=0.03)